GSK (LON:GSK) Receives “Underweight” Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. reissued their underweight rating on shares of GSK (LON:GSK) in a research note released on Monday morning, MarketBeat Ratings reports.

A number of other analysts also recently issued reports on GSK. Deutsche Bank Aktiengesellschaft reiterated a buy rating and issued a GBX 1,950 ($25.08) price objective on shares of GSK in a report on Friday, June 28th. Shore Capital reissued a buy rating on shares of GSK in a research report on Thursday, June 27th. Jefferies Financial Group restated a buy rating and issued a GBX 2,100 ($27.01) price objective on shares of GSK in a report on Thursday, June 27th. Citigroup dropped their target price on GSK from GBX 2,120 ($27.27) to GBX 1,900 ($24.44) and set a buy rating on the stock in a report on Friday, July 5th. Finally, Barclays restated an equal weight rating and issued a GBX 1,725 ($22.19) price target on shares of GSK in a research note on Tuesday, May 7th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and a consensus target price of GBX 1,820 ($23.41).

GSK Stock Down 2.0 %

Shares of GSK stock opened at GBX 1,512 ($19.45) on Monday. The firm has a market cap of £61.69 billion, a PE ratio of 1,387.16, a P/E/G ratio of 1.19 and a beta of 0.27. The business’s 50 day simple moving average is GBX 1,586.30 and its 200 day simple moving average is GBX 1,636.22. The company has a debt-to-equity ratio of 134.34, a quick ratio of 0.73 and a current ratio of 0.87. GSK has a 52-week low of GBX 1,330.19 ($17.11) and a 52-week high of GBX 1,823.50 ($23.46).

GSK Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, October 10th. Investors of record on Thursday, August 15th will be issued a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 0.97%. The ex-dividend date is Thursday, August 15th. GSK’s payout ratio is presently 5,504.59%.

Insider Buying and Selling at GSK

In related news, insider Wendy Becker acquired 446 shares of GSK stock in a transaction on Thursday, June 20th. The stock was purchased at an average cost of GBX 1,614 ($20.76) per share, with a total value of £7,198.44 ($9,259.63). Insiders own 1.60% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.